The implications of commonalities and differences in insulin and GLP-1 secretions would provide deep insights into the coordination between blood glucose levels and the maintenance of body homeostasis
For comprehensive details on managing all Retatrutide side effects during treatment, including timing, severity, and solutions, see our complete guide
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are naturally occurring hormones that regulate appetite, insulin secretion, and metabolism
GLP-1 plays key roles in regulating blood sugar levels by stimulating insulin secretion, reducing glucagon release, slowing digestion, and promoting feelings of fullness
Retatrutide's triple action activating GCG receptors in addition to GIP and GLP-1 enhances the overall effect
This dual-action mechanism enhances its value by promoting greater weight loss results compared to single-agonist therapies like Semaglutide